Division of Molecular Medicine and Gene Therapy
21 – 30 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Reprogramming Stars #23 : Charting Cell Fate Crossroads from the Interplay Between Epigenetics, Transcription, and 3D Chromatin Architecture-An Interview with Dr. Effie Apostolou
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
(2025) In Journal of visualized experiments : JoVE
- Contribution to journal › Article
- 2024
-
Mark
The Impact of Senescent Cells on Limb Regeneration
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #19 : Upgrading Cell Fate Conversions with Engineered Reprogramming Factors-An Interview with Dr. Ralf Jauch
- Contribution to journal › Article
-
Mark
MYCT1 controls environmental sensing in human haematopoietic stem cells
- Contribution to journal › Article
-
Mark
Lipoprotein metabolism mediates hematopoietic stem cell responses under acute anemic conditions
- Contribution to journal › Article
-
Mark
3D cultivation of non-small-cell lung cancer cell lines using four different methods
- Contribution to journal › Article
-
Mark
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
- Contribution to journal › Article
-
Mark
Reprogramming Stars #16 : Reprogramming, from Cells to Embryos-An Interview with Dr. José Silva
- Contribution to journal › Article
